Idiopathic acute transverse myelitis: application of the recent diagnostic criteria.
Iwasaki
Yasuo
Y
Ikeda
Ken
K
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D020274:Autoimmune Diseases of the Nervous System / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000503:physiopathology*; D002555:Cerebrospinal Fluid / Q000166:cytology / Q000276:immunology / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009188:Myelitis, Transverse / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000503:physiopathology*; D009460:Neurologic Examination; D043025:Oligoclonal Bands / Q000134:cerebrospinal fluid; D011237:Predictive Value of Tests; D011379:Prognosis; D011782:Quadriplegia / Q000150:complications; D012189:Retrospective Studies; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology* / Q000503:physiopathology*; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D043025:Oligoclonal Bands